CDIX · Cardiff Lexington Corp · Insider Trading

On April 1, 2026, the Reporting Person was granted a restricted stock award for 5,000 shares of Common Stock under the Issuer's 2024 Equity Incentive Plan, which shall vest quarterly for four (4) quarters commencing on July 1, 2026, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2024 Equity Incentive Plan).

On April 1, 2026, the Reporting Person was granted a restricted stock award for 5,000 shares of Common Stock under the Issuer's 2024 Equity Incentive Plan, which shall vest quarterly for four (4) quarters commencing on July 1, 2026, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2024 Equity Incentive Plan).

On April 1, 2026, the Reporting Person was granted a restricted stock award for 5,000 shares of Common Stock under the Issuer's 2024 Equity Incentive Plan, which shall vest quarterly for four (4) quarters commencing on July 1, 2026, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2024 Equity Incentive Plan).

On January 29, 2026, the Reporting Person entered into a conversion agreement with the Issuer, pursuant to which deferred compensation in the amount of $2,365,242 owed by the Issuer to the Reporting Person was cancelled in exchange for 556,528 shares of common stock.

On January 13, 2026, the Reporting Person was granted a restricted stock award for 62,500 shares of Common Stock under the Issuer's 2024 Equity Incentive Plan, of which 31,250 shares vested on the date of grant and 15,625 shares shall vest on each of January 2, 2027 and January 2, 2028, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2024 Equity Incentive Plan).

On December 11, 2025, the Reporting Person was granted a stock option for the purchase of 50,000 shares of Common Stock under the Issuer's 2024 Equity Incentive Plan, which shall vest quarterly for four (4) quarters commencing on January 1, 2026, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2024 Equity Incentive Plan)

On December 11, 2025, the Reporting Person was granted a restricted stock award for 25,000 shares of Common Stock under the Issuer's 2024 Equity Incentive Plan, which shares shall vest in full on December 11, 2026, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2024 Equity Incentive Plan).

On December 11, 2025, the Reporting Person was granted a stock option for the purchase of 50,000 shares of Common Stock under the Issuer's 2024 Equity Incentive Plan, which shall vest quarterly for four (4) quarters commencing on January 1, 2026, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2024 Equity Incentive Plan)

On December 11, 2025, the Reporting Person was granted a stock option for the purchase of 50,000 shares of Common Stock under the Issuer's 2024 Equity Incentive Plan, which shall vest quarterly for four (4) quarters commencing on January 1, 2026, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2024 Equity Incentive Plan)

Each share of Series I Preferred Stock is convertible into two (2) shares of Common Stock. The Series I Preferred Stock has no expiration date.

On November 19, 2025, all shares of Series I Preferred Stock, including those held by the Reporting Person, were automatically converted into shares of Common Stock.

Each share of Series I Preferred Stock is convertible into two (2) shares of Common Stock. The Series I Preferred Stock has no expiration date.

On November 19, 2025, all shares of Series I Preferred Stock, including those held by the Reporting Person, were automatically converted into shares of Common Stock.

On January 31, 2024, the Reporting Person received 5,000 shares of Series I Preferred Stock as partial compensation for the Reporting Person's services as Chief Financial Officer of the Issuer. Each share of Series I Preferred Stock is convertible into two (2) shares of Common Stock. The Series I Preferred Stock has no expiration date. On November 19, 2025, all shares of Series I Preferred Stock, including those held by the Reporting Person, were automatically converted into shares of Common Stock.

On November 19, 2025, all shares of Series I Preferred Stock, including those held by the Reporting Person, were automatically converted into shares of Common Stock.

On November 19, 2025, all shares of Series I Preferred Stock, including those held by the Reporting Person, were automatically converted into shares of Common Stock.

On January 31, 2024, the Reporting Person received 5,000 shares of Series I Preferred Stock as partial compensation for the Reporting Person's services as Chief Financial Officer of the Issuer. Each share of Series I Preferred Stock is convertible into two (2) shares of Common Stock. The Series I Preferred Stock has no expiration date. On November 19, 2025, all shares of Series I Preferred Stock, including those held by the Reporting Person, were automatically converted into shares of Common Stock.

On September 26, 2025, the Reporting Person was granted a restricted stock award for 5,000 shares of Common Stock under the Issuer's 2024 Equity Incentive Plan, with 1,250 shares vesting on the date of grant and the remaining shares vesting quarterly for three (3) quarters commencing on October 1, 2025, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2024 Equity Incentive Plan).

On September 26, 2025, the Reporting Person was granted a restricted stock award for 5,000 shares of Common Stock under the Issuer's 2024 Equity Incentive Plan, which shares vested in full on the date of grant.

On September 26, 2025, the Reporting Person was granted a restricted stock award for 5,000 shares of Common Stock under the Issuer's 2024 Equity Incentive Plan, with 1,250 shares vesting on the date of grant and the remaining shares vesting quarterly for three (3) quarters commencing on October 1, 2025, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2024 Equity Incentive Plan).

On September 26, 2025, the Reporting Person was granted a restricted stock award for 5,000 shares of Common Stock under the Issuer's 2024 Equity Incentive Plan, with 1,250 shares vesting on the date of grant and the remaining shares vesting quarterly for three (3) quarters commencing on October 1, 2025, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2024 Equity Incentive Plan).

On September 26, 2025, the Reporting Person was granted a restricted stock award for 5,000 shares of Common Stock under the Issuer's 2024 Equity Incentive Plan, which shares vested in full on the date of grant.

On September 26, 2025, the Reporting Person was granted a restricted stock award for 5,000 shares of Common Stock under the Issuer's 2024 Equity Incentive Plan, which shares vested in full on the date of grant.

On September 8, 2025, the Reporting Person transferred 2,496,834 shares of Common Stock to Alexander Hunt Cunningham, Sr. Revocable Trust, of which the Reporting Person is the Trustee.

On September 8, 2025, the Reporting Person transferred 2,496,834 shares of Common Stock to Alexander Hunt Cunningham, Sr. Revocable Trust, of which the Reporting Person is the Trustee.

Each share of Series E Preferred Stock is convertible into two (2) shares of Common Stock. The Series E Preferred Stock has no expiration date.

On April 24, 2025, all shares of Series E Preferred Stock, including those held by the Reporting Person, were automatically converted into shares of Common Stock.

On April 24, 2025, all shares of Series B Preferred Stock, including those held by the Reporting Person, were automatically converted into shares of Common Stock.

On April 24, 2025, all shares of Series E Preferred Stock, including those held by the Reporting Person, were automatically converted into shares of Common Stock.

Each share of Series B Preferred Stock is convertible into two (2) shares of Common Stock. The Series B Preferred Stock has no expiration date.

On April 24, 2025, all shares of Series B Preferred Stock, including those held by the Reporting Person, were automatically converted into shares of Common Stock.

Each share of Series E Preferred Stock is convertible into two (2) shares of Common Stock. The Series E Preferred Stock has no expiration date.

On April 24, 2025, all shares of Series E Preferred Stock, including those held by the Reporting Person, were automatically converted into shares of Common Stock.

On April 24, 2025, all shares of Series E Preferred Stock, including those held by the Reporting Person, were automatically converted into shares of Common Stock.

On April 24, 2025, all shares of Series C Preferred Stock, including those held by the Reporting Person, were automatically converted into shares of Common Stock.

Each share of Series B Preferred Stock is convertible into two (2) shares of Common Stock. The Series B Preferred Stock has no expiration date.

On April 24, 2025, all shares of Series B Preferred Stock, including those held by the Reporting Person, were automatically converted into shares of Common Stock.

On April 24, 2025, all shares of Series B Preferred Stock, including those held by the Reporting Person, were automatically converted into shares of Common Stock.

On April 24, 2025, all shares of Series C Preferred Stock, including those held by the Reporting Person, were automatically converted into shares of Common Stock.

Each share of Series C Preferred Stock is convertible into 10,000 shares of Common Stock. The Series C Preferred Stock has no expiration date.

On April 24, 2025, all shares of Series C Preferred Stock, including those held by the Reporting Person, were automatically converted into shares of Common Stock.

Each share of Series C Preferred Stock is convertible into 10,000 shares of Common Stock. The Series C Preferred Stock has no expiration date.

On April 24, 2025, all shares of Series C Preferred Stock, including those held by the Reporting Person, were automatically converted into shares of Common Stock.

Each share of Series B Preferred Stock is convertible into two (2) shares of Common Stock. The Series B Preferred Stock has no expiration date.

On April 9, 2025, the Reporting Person entered into a cancellation and exchange agreement with the Issuer, pursuant to which the Reporting Person surrendered 195,750 shares of Series I Preferred Stock to the Issuer for cancellation in exchange for the issuance of 150,000 shares of Series B Preferred Stock, 3 shares of Series C Preferred Stock and 27,000 shares of Series E Preferred Stock to the Reporting Person.

Each share of Series I Preferred Stock is convertible into two (2) shares of Common Stock. The Series I Preferred Stock has no expiration date.

On April 9, 2025, the Reporting Person entered into a cancellation and exchange agreement with the Issuer, pursuant to which the Reporting Person surrendered 195,750 shares of Series I Preferred Stock to the Issuer for cancellation in exchange for the issuance of 150,000 shares of Series B Preferred Stock, 3 shares of Series C Preferred Stock and 27,000 shares of Series E Preferred Stock to the Reporting Person.

Each share of Series C Preferred Stock is convertible into 10,000 shares of Common Stock. The Series C Preferred Stock has no expiration date.

On April 9, 2025, the Reporting Person entered into a cancellation and exchange agreement with the Issuer, pursuant to which the Reporting Person surrendered 195,750 shares of Series I Preferred Stock to the Issuer for cancellation in exchange for the issuance of 150,000 shares of Series B Preferred Stock, 3 shares of Series C Preferred Stock and 27,000 shares of Series E Preferred Stock to the Reporting Person.

Each share of Series E Preferred Stock is convertible into two (2) shares of Common Stock. The Series E Preferred Stock has no expiration date.

On April 9, 2025, the Reporting Person entered into a cancellation and exchange agreement with the Issuer, pursuant to which the Reporting Person surrendered 195,750 shares of Series I Preferred Stock to the Issuer for cancellation in exchange for the issuance of 150,000 shares of Series B Preferred Stock, 3 shares of Series C Preferred Stock and 27,000 shares of Series E Preferred Stock to the Reporting Person.

Each share of Series E Preferred Stock is convertible into two (2) shares of Common Stock. The Series E Preferred Stock has no expiration date.

On April 9, 2025, the Reporting Person entered into a cancellation and exchange agreement with the Issuer, pursuant to which the Reporting Person surrendered 195,750 shares of Series I Preferred Stock to the Issuer for cancellation in exchange for the issuance of 150,000 shares of Series B Preferred Stock, 3 shares of Series C Preferred Stock and 27,000 shares of Series E Preferred Stock to the Reporting Person.

Each share of Series C Preferred Stock is convertible into 10,000 shares of Common Stock. The Series C Preferred Stock has no expiration date.

On April 9, 2025, the Reporting Person entered into a cancellation and exchange agreement with the Issuer, pursuant to which the Reporting Person surrendered 195,750 shares of Series I Preferred Stock to the Issuer for cancellation in exchange for the issuance of 150,000 shares of Series B Preferred Stock, 3 shares of Series C Preferred Stock and 27,000 shares of Series E Preferred Stock to the Reporting Person.

Each share of Series B Preferred Stock is convertible into two (2) shares of Common Stock. The Series B Preferred Stock has no expiration date.

On April 9, 2025, the Reporting Person entered into a cancellation and exchange agreement with the Issuer, pursuant to which the Reporting Person surrendered 195,750 shares of Series I Preferred Stock to the Issuer for cancellation in exchange for the issuance of 150,000 shares of Series B Preferred Stock, 3 shares of Series C Preferred Stock and 27,000 shares of Series E Preferred Stock to the Reporting Person.

Each share of Series I Preferred Stock is convertible into two (2) shares of Common Stock. The Series I Preferred Stock has no expiration date.

On April 9, 2025, the Reporting Person entered into a cancellation and exchange agreement with the Issuer, pursuant to which the Reporting Person surrendered 195,750 shares of Series I Preferred Stock to the Issuer for cancellation in exchange for the issuance of 150,000 shares of Series B Preferred Stock, 3 shares of Series C Preferred Stock and 27,000 shares of Series E Preferred Stock to the Reporting Person.

Each share of Series I Preferred Stock is convertible into such number of shares of Common Stock as is determined as follows: (i) if the closing market price of the Common Stock on the principal trading market on which the Common Stock is then traded or quoted is less than $4.00 per share, then each share of Series I Preferred Stock shall be convertible into a number of shares of Common Stock equal to two (2) times the stated value ($4.00 per share), divided by such closing market price on the date of conversion; or (ii) if such closing market price is equal to or greater than $4.00 per share, then each share of Series I Preferred Stock shall be convertible into two (2) shares of Common Stock. The Series I Preferred Stock has no expiration date.

On November 20, 2024, the reporting person entered into a cancellation and exchange agreement with the issuer, pursuant to which the reporting person surrendered 510,704 shares of Series I Preferred Stock to the issuer for cancellation in exchange for the issuance of 375,000 shares of Series B Preferred Stock, 24 shares of Series C Preferred Stock and 50,000 shares of Series E Preferred Stock to the reporting person.

Each share of Series I Preferred Stock is convertible into two (2) shares of Common Stock. The Series I Preferred Stock has no expiration date.

On November 20, 2024, the Reporting Person entered into a cancellation and exchange agreement with the Issuer, pursuant to which the Reporting Person surrendered 510,704 shares of Series I Preferred Stock to the Issuer for cancellation in exchange for the issuance of 375,000 shares of Series B Preferred Stock, 24 shares of Series C Preferred Stock and 50,000 shares of Series E Preferred Stock to the Reporting Person.

Each share of Series B Preferred Stock is convertible at any time into such number of shares of Common Stock as is determined as follows: (i) if the closing market price of the Common Stock on the principal trading market on which the Common Stock is then traded or quoted is less than $4.00 per share, then each share of Series B Preferred Stock shall be convertible into a number of shares of Common Stock equal to two (2) times the stated value ($4.00 per share), divided by such closing market price on the date of conversion; or (ii) if such closing market price is equal to or greater than $4.00 per share, then each share of Series B Preferred Stock shall be convertible into two (2) shares of Common Stock.

On November 20, 2024, the reporting person entered into a cancellation and exchange agreement with the issuer, pursuant to which the reporting person surrendered 510,704 shares of Series I Preferred Stock to the issuer for cancellation in exchange for the issuance of 375,000 shares of Series B Preferred Stock, 24 shares of Series C Preferred Stock and 50,000 shares of Series E Preferred Stock to the reporting person.

The Series B Preferred Stock has no expiration date.

Each share of Series E Preferred Stock is convertible into two (2) shares of Common Stock. The Series E Preferred Stock has no expiration date.

On November 20, 2024, the Reporting Person entered into a cancellation and exchange agreement with the Issuer, pursuant to which the Reporting Person surrendered 510,704 shares of Series I Preferred Stock to the Issuer for cancellation in exchange for the issuance of 375,000 shares of Series B Preferred Stock, 24 shares of Series C Preferred Stock and 50,000 shares of Series E Preferred Stock to the Reporting Person.